Increased porphyrins in primary liver cancer mainly reflect a parallel liver disease (original) (raw)

Hepatocellular carcinoma without cirrhosis: think acute hepatic porphyrias and vice versa

J. Deybach

Journal of Internal Medicine, 2011

View PDFchevron_right

Hepatocellular Carcinoma in Acute Hepatic Porphyrias: Results from the Longitudinal Study of the U.S. Porphyrias Consortium

Karl Anderson

Hepatology, 2020

View PDFchevron_right

High risk of primary liver cancer in a cohort of 179 patients with Acute Hepatic Porphyria

Staffan Wahlin

Journal of Inherited Metabolic Disease, 2013

View PDFchevron_right

Comment on Ramai et al. Risk of Hepatocellular Carcinoma in Patients with Porphyria: A Systematic Review. Cancers 2022, 14, 2947

Eliane Sardh

Cancers, 2023

View PDFchevron_right

Reply to Lissing et al. Comment on “Ramai et al. Risk of Hepatocellular Carcinoma in Patients with Porphyria: A Systematic Review. Cancers 2022, 14, 2947”

Sara di nunzio

Cancers

View PDFchevron_right

Risk of Hepatocellular Carcinoma in Patients with Porphyria: A Systematic Review

Sara di nunzio

Cancers, 2022

View PDFchevron_right

Hepatocellular Carcinoma in Acute Intermittent Porphyria: Incidental or Expected?

Nazia Khan

American Journal of Medical Case Reports, 2015

View PDFchevron_right

Stimulators and Inhibitors of Hepatic Porphyrin Formation in Human Sera

Robert Winchester

Journal of Clinical Investigation, 1974

View PDFchevron_right

Sn-protoporphyrin suppresses chemically induced experimental hepatic porphyria. Potential clinical implications

George Drummond

Journal of Clinical Investigation, 1985

View PDFchevron_right

An analysis of the porphyrins of normal and cirrhotic human liver and normal bile

mohammed aziz

Clinica Chimica Acta, 1969

View PDFchevron_right

Porphyrins in urine after administration of 5-aminolevulinic acid as a potential tumor marker

Fuminori Abe

Photodiagnosis and Photodynamic Therapy

View PDFchevron_right

Acute Hepatic Porphyria – Minireview

ANDREI VICENTIU EDU

Modern Medicine, 2023

View PDFchevron_right

Acute hepatic porphyrias: Current diagnosis & management

Karl Anderson

Molecular Genetics and Metabolism, 2019

View PDFchevron_right

Disease burden in patients with acute hepatic porphyria: experience from the phase 3 ENVISION study

Ilja Kubisch

Orphanet Journal of Rare Diseases

View PDFchevron_right

Porphyrins are increased in the faeces of patients with prostate cancer: a case-control study

Lilia Coronato Courrol

BMC Cancer, 2018

View PDFchevron_right

Current and innovative emerging therapies for porphyrias with hepatic involvement

Karl Anderson

Journal of Hepatology, 2019

View PDFchevron_right

Porphyrin metabolism in rats intaking chemical carcinogens

Wafaa Yousef

Cancer Letters, 1998

View PDFchevron_right

EXPLORE: A Prospective, Multinational, Natural History Study of Patients with Acute Hepatic Porphyria with Recurrent Attacks

Eliane Sardh

Hepatology

View PDFchevron_right

Acute Intermittent Porphyria : Studies of chronic disease, recombinant enzyme therapy and late complications

Eliane Sardh

2008

View PDFchevron_right

Acute hepatic porphyrias: Recommendations for evaluation and long‐term management

Karl Anderson

Hepatology, 2017

View PDFchevron_right

Hepatic porphyrin concentration and uroporphyrinogen decarboxylase activity in hepatitis C virus infection

Pascale Trimoulet

Journal of Viral Hepatitis, 2008

View PDFchevron_right

Variations in Porphobilinogen and 5-Aminolevulinic Acid Concentrations in Plasma and Urine from Asymptomatic Carriers of the Acute Intermittent Porphyria Gene with Increased Porphyrin Precursor Excretion

Pauline Harper, Eliane Sardh

Clinical Chemistry, 2006

View PDFchevron_right

Acute hepatic porphyria

Kilian LaFreniere

Definitions, 2020

View PDFchevron_right

Heme utilization by rat liver tryptophan pyrrolase as a screening test for exacerbation of hepatic porphyrias by drugs

Abdulla Badawy

Journal of pharmacological methods, 1981

View PDFchevron_right

Hepatocellular carcinoma risk in patients with porphyria cutanea tarda

Sara Battistella

European Journal of Gastroenterology & Hepatology, 2004

View PDFchevron_right

Distribution of 5-AMINOLEVULINIC Acid-Induced Porphyrins in Noduloulcerative Basal Cell Carcinoma

Karl-Erik Giercksky

Photochemistry and Photobiology, 2008

View PDFchevron_right

Naturally-occurring porphyrins in a spontaneous-tumour bearing mouse model

Giovanni Bottiroli

Photochemical & Photobiological Sciences, 2011

View PDFchevron_right

Review: Molecular pathogenesis of hepatic acute porphyrias

Bernard Grandchamp

Journal of Gastroenterology and Hepatology, 1996

View PDFchevron_right

Liver Transplantation for Acute Intermittent Porphyria: Biochemical and Pathologic Studies of the Explanted Liver

Karl Anderson

Molecular Medicine, 2015

View PDFchevron_right

Recurrent attacks of acute hepatic porphyria: major role of the chronic inflammatory response in the liver

Constance Delaby

Journal of Internal Medicine, 2018

View PDFchevron_right